These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 29724202)
21. Splenic abscess due to brucellosis: a case report and a review of the literature. Yilmaz M; Arslan F; Başkan O; Mert A Int J Infect Dis; 2014 Mar; 20():68-70. PubMed ID: 24433982 [TBL] [Abstract][Full Text] [Related]
23. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4. Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881 [TBL] [Abstract][Full Text] [Related]
24. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection. Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302 [TBL] [Abstract][Full Text] [Related]
25. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy. Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866 [TBL] [Abstract][Full Text] [Related]
26. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis. Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618 [TBL] [Abstract][Full Text] [Related]
28. Hydrophobic gentamicin-loaded nanoparticles are effective against Brucella melitensis infection in mice. Imbuluzqueta E; Gamazo C; Lana H; Campanero MÁ; Salas D; Gil AG; Elizondo E; Ventosa N; Veciana J; Blanco-Prieto MJ Antimicrob Agents Chemother; 2013 Jul; 57(7):3326-33. PubMed ID: 23650167 [TBL] [Abstract][Full Text] [Related]
29. Protection of BALB/c mice against Brucella melitensis 16 M infection induced by vaccination with live Escherchia coli expression Brucella P39 protein. Al-Mariri A Vaccine; 2010 Feb; 28(7):1766-70. PubMed ID: 20036752 [TBL] [Abstract][Full Text] [Related]
30. Immuno-pathophysiological responses of mouse model to experimental infection with Brucella melitensis and its lipopolysaccharides via intraperitoneal route. Osman AY; Abdullah FFJ; Kadir AA; Saharee AA Microb Pathog; 2016 Nov; 100():17-29. PubMed ID: 27591112 [TBL] [Abstract][Full Text] [Related]
31. Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge. Kahl-McDonagh MM; Arenas-Gamboa AM; Ficht TA Infect Immun; 2007 Oct; 75(10):4923-32. PubMed ID: 17664263 [TBL] [Abstract][Full Text] [Related]
32. Brucella melitensis sternal osteomyelitis following median sternotomy. Chin YT; Krishnan M; Burns P; Qamruddin A; Hasan R; Dodgson AR J Infect Chemother; 2014 Sep; 20(9):574-6. PubMed ID: 24910374 [TBL] [Abstract][Full Text] [Related]
33. Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model. Tadepalli G; Singh AK; Balakrishna K; Murali HS; Batra HV Mol Immunol; 2016 Mar; 71():34-41. PubMed ID: 26826463 [TBL] [Abstract][Full Text] [Related]
34. [Ciprofloxacin in the treatment of patients with brucellosis]. Duĭsenova AK; Kurmanova KB; Kurmanova GM Antibiot Khimioter; 2002; 47(10):3-7. PubMed ID: 12674788 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of immunogenicity and protective activity in BALB/c mice of the 25-kDa major outer-membrane protein of Brucella melitensis (Omp25) expressed in Escherichia coli. Bowden RA; Cloeckaert A; Zygmunt MS; Dubray G J Med Microbiol; 1998 Jan; 47(1):39-48. PubMed ID: 9449948 [TBL] [Abstract][Full Text] [Related]
36. Protective role of antibodies induced by Brucella melitensis B115 against B. melitensis and Brucella abortus infections in mice. Adone R; Francia M; Pistoia C; Petrucci P; Pesciaroli M; Pasquali P Vaccine; 2012 Jun; 30(27):3992-5. PubMed ID: 22521283 [TBL] [Abstract][Full Text] [Related]
37. Comparative experimental study of Brucella melitensis and its lipopolysaccharide in mouse model infected via subcutaneous route of exposure. Osman AY; Saharee AA; Jesse FF; Kadir AA Microb Pathog; 2018 Mar; 116():318-327. PubMed ID: 29412161 [TBL] [Abstract][Full Text] [Related]
38. B. melitensis rough strain B115 is protective against heterologous Brucella spp. infections. Adone R; Francia M; Pistoia C; Pesciaroli M; Pasquali P Vaccine; 2011 Mar; 29(14):2523-9. PubMed ID: 21300102 [TBL] [Abstract][Full Text] [Related]